Literature DB >> 24106984

Clinical differences in Clostridium difficile infection based on age: a multicenter study.

Hyung Hun Kim1, You Sun Kim, Dong Soo Han, Young-Ho Kim, Won Ho Kim, Joo Sung Kim, Hyunsoo Kim, Hyun-Soo Kim, Young-Sook Park, Hyun Joo Song, Sung Jae Shin, Suk-Kyun Yang, Byong Duk Ye, Chang Soo Eun, Kang-Moon Lee, Sang Heon Lee, Byung-Ik Jang, Sung-Ae Jung, Jae Hee Cheon, Chang Hwan Choi, Kyuchan Huh.   

Abstract

Advancing age is a well-known risk factor for Clostridium difficile infection (CDI). However, age-specific clinical differences in CDI are uncertain. A retrospective comparative analysis was performed based on age in 1367 patients with CDI in Korea. Most clinical features were similar in the two age groups studied, however malignancy was more common in the older group (age ≥ 65 y) (p < 0.001), while chemotherapy and transplantation were more common in the younger group (age < 65 y) (p < 0.001). Endoscopic examinations were more commonly performed in the older group (p = 0.010), which had a high positive predictive value (88.3%). More patients recovered from CDI without specific antibiotic treatment in the younger group than in the older group (p < 0.001). Although advancing age is an important risk factor for CDI, the clinical features of younger patients are similar to those of the older patient population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24106984     DOI: 10.3109/00365548.2013.840918

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 2.  Management of inflammatory bowel disease in older persons: evolving paradigms.

Authors:  Saurabh Kedia; Jimmy K Limdi; Vineet Ahuja
Journal:  Intest Res       Date:  2018-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.